asthma
chronic
diseas
current
affect
million
peopl
worldwid
anticip
increas
million
approxim
asthmarel
death
report
yearli
mani
avoid
christiansen
zuraw
pathogenesi
asthma
still
well
understood
diseas
link
sever
genet
environment
infecti
nutrit
factor
earli
asthma
describ
singl
diseas
understand
complex
evolv
point
precis
medicin
approach
includ
microbiom
analysi
start
emerg
diagnosi
treatment
desai
oppenheim
taylor
et
al
given
huge
number
differ
microorgan
colon
human
bodi
intim
contact
human
cell
multipl
influenc
host
human
microbiom
longer
consid
inert
microbi
commun
respiratori
gastrointestin
tract
essenti
maintain
human
health
healthi
adult
microbiota
includ
bacteria
virus
fungi
even
archaea
divers
stabl
resist
resili
mean
rich
mani
differ
speci
normal
return
preperturb
state
levi
et
al
microbi
dysbiosi
within
lung
gut
asthma
caus
mani
factor
relat
lifestyl
environment
exposur
imbal
symbiot
patholog
bacteri
strain
gut
lung
may
lead
alter
immun
develop
inappropri
inflammatori
respons
still
unclear
whether
imbal
caus
effect
diseas
review
address
question
focu
role
lung
gut
microbiota
develop
mainten
respiratori
health
disturb
differ
subtyp
asthma
asthma
character
larg
spectrum
clinic
observ
phenotyp
even
larger
rang
underli
molecular
immunolog
mechan
call
endotyp
wenzel
sugita
et
al
boutin
et
al
current
best
understand
complex
endotyp
mechanist
pathogenet
process
lay
dualist
divis
type
nontyp
asthma
agach
akdi
figur
howev
often
endotyp
coexist
andor
includ
mix
process
easili
categor
kuo
et
al
agach
akdi
et
al
less
welldefin
form
asthma
situat
clinic
phenotyp
molecular
endotyp
includ
inflammatori
phenotyp
eosinophil
neutrophil
mix
paucigranulocyt
asthma
wang
et
al
tan
et
al
type
asthma
usual
observ
clinic
earlyonset
allerg
asthma
lateonset
eosinophil
asthma
exerciseinduc
asthma
fahi
patient
usual
allerg
common
aeroallergen
high
blood
eosinophilia
increas
periostin
high
exhal
nitric
oxid
tend
respond
well
treatment
glucocorticosteroid
novel
biolog
antiimmunoglobulin
e
ige
approach
castro
et
al
corren
et
al
howev
within
high
eosinophil
asthma
also
whose
eosinophilia
resist
steroid
treatment
other
persist
sever
asthma
demonstr
rapid
declin
lung
function
enhanc
airway
remodel
frequent
exacerb
chung
et
al
pavlidi
et
al
mechanist
type
inflamm
engag
helper
th
type
cell
type
innat
lymphoid
cell
follicular
helper
cell
type
b
cell
eosinophil
mast
cell
signatur
type
mediat
includ
cytokin
well
prostaglandin
ray
koll
figur
nontyp
asthma
observ
often
obesityrel
asthma
neutrophil
asthma
paucigranulocyt
asthma
kuo
et
al
et
al
ray
koll
usual
connect
poor
respons
steroid
sever
phenotyp
even
childhood
ramratnam
et
al
nontyp
inflamm
character
infiltr
cell
neutrophil
presenc
type
interferon
inflammasom
activ
signatur
rossio
et
al
kim
et
al
tan
et
al
effect
microbiota
dysbiosi
asthma
heterogen
seem
intuit
recent
taylor
et
al
boutin
et
al
lung
gut
microbiom
composit
address
schemat
represent
asthma
phenotyp
endotyp
differ
microbiota
endotyp
endotyp
classifi
asthma
base
pathophysiolog
mechan
wherea
phenotyp
refer
clinic
morpholog
descript
diseas
two
bestdescrib
asthma
endotyp
type
endotyp
includ
mostli
cell
respons
nontyp
endotyp
howev
endotyp
coexist
andor
includ
mix
process
type
asthma
usual
observ
clinic
earlyonset
allerg
asthma
lateonset
eosinophil
asthma
exerciseinduc
asthma
nontyp
asthma
mechan
observ
usual
neutrophil
obesityrel
paucigranulocyt
phenotyp
b
simplifi
cellular
mechan
involv
asthma
correl
microbiota
inflamm
engag
th
cell
type
innat
lymphoid
cell
follicular
helper
cell
type
b
cell
eosinophil
mast
cell
result
increas
amount
prostaglandin
sputum
bal
serum
bronchial
biopsi
nontyp
asthma
character
infiltr
cell
neutrophil
presenc
type
interferon
inflammasom
cytokin
studi
clinic
inflammatori
phenotyp
endotyp
asthma
microb
alreadi
inhabit
everi
environment
nich
earth
includ
extrem
prior
human
therefor
surpris
surfac
human
bodi
includ
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
popul
microbi
commun
yet
even
upon
initi
human
microbiom
project
turnbaugh
et
al
lung
sampl
partial
due
exist
dogma
time
lung
steril
dogma
significantli
delay
initi
studi
lung
microbiota
rel
gut
microbiota
dickson
et
al
moffatt
cookson
like
persist
sever
reason
healthi
lung
often
examin
invas
bronchoscopi
techniqu
due
ethic
concern
culturebas
techniqu
limit
known
pathogen
bronchoscopi
techniqu
suspect
carri
contamin
oropharynx
nasal
caviti
howev
pioneer
public
use
cultureindepend
rrna
sequenc
reveal
differ
microbi
commun
found
variou
locat
healthi
respiratori
tract
rel
found
respiratori
tract
patient
asthma
chronic
obstruct
pulmonari
diseas
copd
hilti
et
al
numer
studi
confirm
observ
follow
elucid
special
role
airway
microbiota
health
man
et
al
diseas
wypych
et
al
respiratori
system
human
consist
urt
start
nasal
caviti
follow
nasopharynx
oropharynx
larynx
vocal
cord
lrt
continu
larynx
vocal
cord
includ
trachea
bronchi
bronchiol
countless
alveoli
lung
weibel
surfac
area
human
respiratori
tract
inhabit
microbiota
differ
quantiti
qualiti
along
tract
respons
nichespecif
condit
man
et
al
huffnagl
et
al
movement
air
particl
includ
microbiota
respiratori
system
bidirect
composit
lung
microbiom
site
thu
consequ
balanc
reach
migrat
airway
elimin
airway
sitespecif
immun
process
eg
presenc
absenc
inflamm
growth
rate
microb
highlight
role
urt
gatekeep
respiratori
health
man
et
al
microbiota
enter
lung
mainli
via
microaspir
nasopharynx
dens
divers
popul
oropharynx
microb
also
enter
lung
via
dispers
along
mucos
surfac
bassi
et
al
dickson
et
al
bacteria
healthi
urt
includ
genera
staphylococcu
propionibacterium
dolosigranulum
corynebacterium
moraxella
streptococcu
haemophilu
rothia
veillonella
prevotella
leptotrichia
zhou
et
al
frank
et
al
wosoxley
et
al
addit
bacteria
sever
virus
fungi
found
urt
healthi
peopl
human
rhinoviru
rv
bocaviru
adenoviru
coronaviru
polymaviru
annelovirida
famili
virus
identifi
urt
larg
proport
healthi
asymptomat
children
use
pcrbase
method
metagenom
even
geograph
isol
locat
van
den
bergh
et
al
bogaert
et
al
wyli
et
al
altan
et
al
detect
frequenc
virus
mani
studi
differ
urt
asymptomat
control
children
hospit
due
respiratori
tract
infect
contrast
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
parainfluenza
virus
piv
influenza
causal
associ
hospit
lower
respiratori
symptom
pneumonia
singleton
et
al
sarna
et
al
bhuiyan
et
al
data
suggest
case
commonli
carri
urt
virus
presenc
rather
total
viral
load
jansen
et
al
complex
interact
virus
bacteria
van
den
bergh
et
al
environment
eg
allergen
intrins
host
factor
eg
sensit
rubner
et
al
determin
occurr
diseas
urt
lrt
interestingli
healthi
adult
virus
detect
less
frequent
asymptomat
children
suggest
agedepend
perhap
ecosystemdepend
chang
viral
load
urt
sundel
et
al
aspergillu
penicillium
candida
alternaria
fungal
genera
found
urt
healthi
peopl
charlson
et
al
healthi
lung
lrt
six
domin
bacteri
phyla
firmicut
includ
genera
streptococcu
veillonella
bacteroid
includ
genu
prevotella
proteobacteria
fusobacteria
acidobacteria
actinobacteria
includ
tropheryma
whipplei
segal
et
al
dickson
et
al
dickson
et
al
virom
healthi
lung
contain
member
anellovirida
famili
high
frequenc
variou
bacteriophag
abba
et
al
willner
et
al
jankauskait
e
et
al
abund
greater
context
immunosuppress
andor
chronic
diseas
freer
et
al
suggest
immunocompet
prerequisit
low
abund
biodivers
lrt
virom
lung
mycobiom
compos
eremothecium
systenostrema
malassezia
genera
davidiellacea
famili
charlson
et
al
van
woerden
et
al
major
cite
studi
use
genet
techniqu
identifi
microorgan
taxa
result
usual
confirm
culturedepend
method
howev
sequenc
allow
identif
divers
microb
limit
viabil
abil
grow
microorgan
vitro
studi
underscor
healthi
microbiom
rather
transient
lung
steadi
state
contrast
diseas
inflammatori
condit
enabl
growth
certain
bacteria
lead
dysbiosi
subsequ
colon
pathogen
healthi
microbiom
urt
lrt
play
sever
import
role
develop
mainten
homeostasi
rt
whole
organ
composit
microbiom
mucos
site
chang
dynam
first
day
life
shape
establish
proper
interact
microbiota
human
bodi
constitut
critic
window
opportun
determin
futur
health
diseas
pattaroni
et
al
pammi
et
al
stiemsma
turvey
directli
birth
skin
gut
nasopharynx
mouth
microbi
commun
undifferenti
colon
bacteri
speci
reflect
deliveri
mode
de
steenhuijsen
piter
et
al
birth
first
day
life
matern
vagin
skin
microbiota
transient
transfer
infant
wherea
mother
gut
microbiota
becom
primari
sourc
microbi
strain
acquir
babi
age
four
month
ferretti
et
al
yassour
et
al
separ
urt
lrt
context
earli
life
import
two
anatom
site
repres
differ
habitat
urt
experi
constant
exposur
extern
environ
accompani
condit
first
moment
life
shape
urt
microbiota
howev
demonstr
h
birth
bacteri
dna
detect
lrt
neonat
wypych
et
al
transient
natur
lrt
microbiota
steadi
state
determin
balanc
microbiota
enter
urt
microbiota
elimin
host
immun
therefor
urt
sampl
fulli
reflect
interact
occur
lrt
wypych
et
al
healthi
respiratori
tract
microbiom
play
also
import
role
confer
colon
resist
term
colon
resist
refer
abil
healthi
time
microbiota
activ
suppress
compet
pathogen
inhibit
outgrowth
shown
vitro
bomar
et
al
vivo
overal
influenc
healthi
airway
microbiota
host
immun
reflect
cumul
effect
live
microb
compon
cell
metabolit
local
system
innat
adapt
immun
process
host
segal
et
al
wang
et
al
process
healthi
time
colon
disrupt
earlylif
dysbiosi
gut
lung
microbiota
becom
import
risk
factor
develop
mani
respiratori
diseas
biesbroek
et
al
teo
et
al
mechan
involv
like
oper
differ
mode
eg
via
inadequ
train
host
immun
ineffici
colon
resist
de
steenhuijsen
piter
et
al
andor
improp
lung
morphogenesi
yun
et
al
utero
develop
later
life
sever
direct
indirect
factor
affect
healthi
microbiota
colon
subsequ
hostmicrobiota
interact
factor
includ
mother
health
statu
stokholm
et
al
diet
frei
et
al
barcik
et
al
transfer
matern
antibodi
microbi
molecul
gomez
de
uero
et
al
koch
et
al
mode
deliveri
bosch
et
al
breastfeed
earlylif
environ
day
care
sibl
wolsk
et
al
pet
home
sitarik
et
al
tun
et
al
tradit
farmlik
dust
home
stein
et
al
kirjavainen
et
al
smoke
antibiot
drug
usag
pregnanc
earli
childhood
mitr
et
al
loewen
et
al
human
gut
start
oral
caviti
continu
esophagu
stomach
small
intestin
colon
end
rectum
enorm
surfac
area
provid
microb
opportun
colon
transient
occup
inde
human
gut
inhabit
thousand
billion
bacteria
per
ml
lumin
content
depend
region
therefor
dens
colon
organ
sender
et
al
bacteria
within
gut
confer
sever
function
host
includ
vitamin
product
absorpt
ion
protect
pathogen
histolog
develop
enhanc
immun
function
ferment
food
hillman
et
al
typic
domin
five
phyla
bacteroidet
firmicut
proteobacteria
actinobacteria
tenericut
desai
oppenheim
almeida
et
al
wherea
bacteroid
faecalibacterium
bifidobacterium
preval
genera
healthi
adult
marsland
et
al
oral
caviti
mainli
colon
bacteria
streptococcacea
pasteurellacea
veillonellacea
prevotellaeac
neisseriacea
famili
gemella
genu
stomach
mostli
contain
bacteria
lactobacillacea
famili
small
intestin
domin
lactobacillacea
enterobacteriacea
streptococcacea
dens
colon
larg
intestin
contain
bacteria
famili
enterococcacea
clostridiacea
enterobacteriacea
bacteroidacea
bifidobacteriacea
fusobacteriacea
lactobacillacea
peptostreptococcacea
peptococcacea
prevotellaeac
lachnospiracea
ruminococcacea
rikenelleac
phylum
verrucomimicrobia
hillman
et
al
pereira
berri
candida
saccharomyc
malassezia
cladosporium
among
commonli
consist
identifi
fungal
genera
human
gut
mycobiota
studi
hoffmann
et
al
strati
et
al
auchtung
et
al
mahnic
rupnik
iliev
leonardi
besid
bacteria
fungi
human
gut
microbiota
addit
compos
virus
primarili
phage
archaea
mainli
methanobrevibact
smithii
lozupon
et
al
connect
lung
gut
repeatedli
demonstr
human
mous
studi
induc
bronchusassoci
lymphoid
tissu
ibalt
gutassoci
lymphoid
tissu
galt
part
mucosalassoci
lymphoid
tissu
relat
morpholog
function
includ
regul
local
immun
respons
elmor
main
immunolog
function
galt
ibalt
includ
product
secret
iga
mucos
surfac
well
th
cell
cytotox
tc
respons
cesta
regul
local
immun
galt
occur
peyer
patch
mesenter
lymph
node
termin
transform
b
cell
plasma
cell
abl
secret
antibodi
final
lamina
propria
memori
effector
b
cell
resid
importantli
activ
b
cell
adult
found
gut
mucos
tissu
brandtzaeg
concept
gutlung
connect
born
observ
differ
lung
diseas
influenc
intestin
microenviron
chang
vice
versa
microbiota
import
factor
respons
interact
two
site
asthma
marsland
et
al
addit
gut
microbiota
patient
sever
bacteri
pneumonia
chung
cystic
fibrosi
marsland
et
al
influenza
differ
healthi
control
qin
et
al
mani
studi
show
earli
life
import
period
microbiota
dysbiosi
gut
may
lead
develop
mani
respiratori
diseas
gut
microbiota
signific
influenc
immun
cell
matur
resist
pathogen
mechan
mediat
commun
gut
lung
still
unclear
suggest
epitheli
cell
structur
cell
immun
cell
absorb
signal
endothelium
form
local
cytokin
microenviron
lead
chang
immun
respons
distal
site
budden
et
al
naiv
immun
cell
initi
activ
gut
travel
via
lymph
blood
vessel
lung
effector
function
importantli
local
immun
reaction
galt
ibalt
influenc
system
immun
respons
mucos
immun
system
also
act
independ
system
site
cesta
interestingli
emerg
evid
indic
gutlung
axi
bidirect
instanc
stimul
mous
lung
lipopolysaccharid
lp
caus
signific
increas
number
bacteria
gut
sze
et
al
shown
pneumonia
induc
intestin
injuri
perron
et
al
decreas
gut
epitheli
prolifer
coopersmith
et
al
figur
addit
gutlungliv
axi
describ
copd
young
et
al
shortchain
fatti
acid
scfa
deriv
gut
bacteria
inhibitori
effect
proinflammatori
respons
lung
one
propos
mechan
liver
dampen
innat
immun
respons
scfa
bind
gprotein
receptor
inhibit
mevalon
pathway
hmgcoa
reductas
young
et
al
furthermor
mous
model
pneumonia
shown
cytokin
express
airspac
macrophag
depend
acutephas
protein
characterist
hepat
acutephas
respons
extravas
alveoli
data
suggest
liver
respons
enhanc
macrophag
activ
pulmonari
inflamm
hilliard
et
al
human
gut
dens
colon
site
human
bodi
sender
et
al
commun
bacteria
correl
asthma
earli
life
establish
diseas
requir
special
attent
lachnospira
veillonella
faecalibacterium
rothia
genera
significantli
decreas
rel
abund
fecal
sampl
threemonthold
canadian
children
high
risk
asthma
bacteri
signatur
longer
evid
age
year
accompani
reduc
amount
fecal
acet
dysregul
enterohepat
metabolit
moreov
predict
bacteri
commun
function
analysi
show
reduct
lp
biosynthesi
pathway
microbiota
children
high
risk
asthma
arrieta
et
al
ovalbumin
ova
induc
mous
model
airway
inflamm
supplement
fecal
slurri
infant
develop
asthma
transplant
germfre
mice
repres
speci
lachnospira
veillonella
faecalibacterium
rothia
genera
decreas
airway
inflamm
arrieta
et
al
anoth
human
birth
cohort
studi
ecuadorian
children
increas
rel
abund
streptococcu
bacteroid
speci
decreas
bifidobacterium
speci
ruminococcu
gnavu
fecal
sampl
month
age
higher
risk
develop
atopi
wheez
age
year
arrieta
et
al
final
among
neonat
unit
state
group
three
cluster
accord
composit
gut
microbiota
lowest
rel
abund
bifidobacteria
akkermansia
faecalibacterium
genera
higher
rel
abund
candida
rhodotorula
fungi
highest
risk
develop
atopi
asthma
fujimura
et
al
figur
effect
gut
microbiota
asthma
least
partial
mediat
bacteri
metabolit
may
influenc
immun
respons
distal
part
bodi
known
metabolit
demonstr
protect
properti
human
airway
inflamm
scfa
children
high
amount
butyr
propion
fece
year
age
significantli
less
atop
sensit
less
like
asthma
year
roduit
et
al
moreov
solubl
fiber
supplement
found
decreas
sputum
eosinophilia
sputum
histon
deacetylas
gene
express
asthma
patient
mcloughlin
et
al
mice
scfa
shown
increas
express
transcript
factor
via
inhibit
histon
deacetyl
therebi
support
expans
regulatori
cell
treg
increas
product
arpaia
et
al
scfa
also
shown
reduc
inflamm
ova
hous
dust
mite
hdm
induc
airway
inflamm
model
cait
et
al
moreov
oral
applic
scfa
mice
pregnanc
wean
protect
offspr
allerg
lung
inflamm
butyr
particular
potent
induc
treg
lung
offspr
roduit
et
al
figur
recent
interest
studi
show
gut
bacteria
human
abl
produc
metabolit
proand
antiinflammatori
potenti
biogen
amin
includ
histamin
pugin
et
al
oxylipin
levan
et
al
number
histaminesecret
bacteria
significantli
higher
fecal
sampl
asthma
patient
compar
nonasthmat
volunt
addit
number
histaminesecret
bacteria
correl
diseas
sever
howev
model
ovainduc
allerg
airway
inflamm
bacteriaderiv
histamin
decreas
total
cell
number
bronchoalveolar
fluid
bal
amount
lung
homogen
highlight
complex
bacteriaderiv
immun
regul
convers
intraabdomin
treatment
mice
decreas
number
treg
cell
lung
increas
pulmonari
inflamm
cockroach
antigen
mous
model
airway
inflamm
levan
et
al
figur
metabolit
secret
lung
gut
bacteria
might
prove
use
addit
therapeut
approach
lung
proteobacteria
appear
repeatedli
domin
phylum
overrepres
patient
asthma
compar
nonasthmat
volunt
across
sever
human
studi
huang
et
al
marri
et
al
zhang
et
al
hilti
et
al
proteobacteria
phylum
repres
potenti
pathogen
bacteria
includ
belong
genera
haemophilu
moraxella
neisseria
huang
et
al
caverli
et
al
within
asthmat
inflammatori
phenotyp
patient
neutrophil
asthma
usual
receiv
high
dose
inhal
corticosteroid
icss
demonstr
less
divers
bacteri
load
rel
enrich
haemophilu
moraxella
speci
member
proteobacteria
phylum
reduct
rel
abund
streptococcu
gemella
porphyromona
taxa
compar
patient
eosinophil
asthma
taylor
et
al
simpson
et
al
green
et
al
patient
sever
asthma
cell
epitheli
gene
signatur
repres
nontyp
asthma
associ
increas
represent
phylum
proteobacteria
correl
worsen
asthma
control
huang
et
al
neutrophil
exacerb
asthma
ghebr
et
al
klebsiella
one
genu
bacteria
within
proteobacteria
phylum
enrich
specif
patient
sever
asthma
wherea
phylum
actinobacteria
correl
improv
chang
asthma
control
indic
complex
identifi
causeandeffect
relationship
chang
microbi
commun
lung
may
also
result
asthma
therapi
actinobacteria
instanc
associ
molecular
evid
respons
steroid
express
huang
et
al
certain
airway
microbiota
may
therefor
potenti
use
indic
asthma
respons
steroid
allow
clinician
refin
therapi
importantli
substanti
addit
effect
obes
asthma
sever
host
immunolog
respons
airway
gut
microbiota
recent
describ
obes
nonobes
asthma
patient
sever
diseas
reduc
fecal
level
akkermansia
muciniphila
may
causal
relationship
shown
murin
model
acut
chronic
airway
inflamm
michalovich
et
al
anoth
genu
present
lung
patient
sever
asthma
streptococcu
zhang
et
al
budden
et
al
subject
atop
asthma
usual
eosinophil
inflammatori
phenotyp
demonstr
enrich
bacteria
genera
fusobacterium
porphyromona
sphingomonodacea
famili
decreas
rel
abund
member
mogibacteriacea
famili
lactobacillal
order
durack
et
al
addit
eosinophil
sputum
asthma
patient
connect
presenc
tropheryma
whipplei
human
adult
simpson
et
al
contrast
surprisingli
reproduc
find
neutrophil
asthma
statu
microbiota
eosinophil
type
asthma
less
clear
heterogen
potenti
reflect
differ
underli
endotyp
mix
respons
caus
ic
treatment
current
remain
unclear
extent
divers
presenc
specif
bacteria
airway
adult
patient
asthma
reflect
type
inflamm
microbi
respons
corticosteroid
treatment
demonstr
treatment
combin
icss
oral
glucocorticoid
correl
posit
increas
abund
proteobacteria
pseudomona
decreas
abund
bacteroidet
fusobacteria
prevotella
denner
et
al
hand
studi
mild
asthmat
treat
icss
demonstr
uniqu
enrich
member
haemophilu
neisseria
fusobacterium
porphyromona
speci
sphingomonodacea
famili
concurr
deplet
member
mogibacteriacea
famili
lactobacillal
airway
durack
et
al
togeth
studi
suggest
lung
microbiom
composit
patient
asthma
often
treat
corticosteroid
probabl
result
complex
interact
inflammatori
milieu
drug
effect
infect
mice
moraxella
catarrhali
catarrhali
proteobacterium
phyla
result
neutrophil
infiltr
high
concentr
tumor
necrosi
factor
tnfa
moder
concentr
cellderiv
ifng
lung
day
infect
moreov
neutral
tnfa
result
acceler
clearanc
catarrhali
effect
prevent
infectioninduc
exacerb
allerg
airway
inflamm
alnaha
et
al
furthermor
haemophilu
influenza
proteobacteroium
phyla
abl
convert
steroidsensit
allerg
airway
diseas
aad
associ
cell
eosinophil
steroidresist
diseas
associ
cell
neutrophil
domin
respons
essilfi
et
al
increasingli
larg
bodi
evid
suggest
role
bacteria
asthma
studi
need
clearli
defin
import
speci
involv
understand
whether
bacteri
dysbiosi
context
asthma
caus
effect
diseas
detail
mechanist
studi
necessari
gain
full
understand
complex
associ
lung
gut
microbiota
composit
metabol
differ
point
life
specif
type
asthmat
inflamm
even
immunolog
mechan
earlylif
protect
describ
probabl
mani
other
addit
immunolog
molecular
mechan
alreadi
establish
dysbiosi
adult
asthma
need
character
detail
ideal
revers
process
moreov
attent
paid
understand
connect
patient
microbiom
respons
asthma
therapi
may
influenc
one
anoth
microbialderiv
mechan
might
reason
poor
respons
treatment
elegantli
demonstr
vaccin
hagan
et
al
final
futur
work
focu
continu
character
detail
cellular
molecular
mechan
mediat
commun
bacteria
host
asthma
microb
import
group
microb
togeth
compris
rare
biospher
lynch
neufeld
jousset
et
al
microbiota
includ
fungi
microeukaryot
remain
unclear
whether
fungi
colon
healthi
adult
gut
simpli
detect
sequenc
studi
transient
oral
foodderiv
fungi
auchtung
et
al
even
transient
colon
gut
potenti
impact
microbi
commun
ecolog
host
immun
respons
hallenadam
suhr
although
mechan
involv
explor
two
recent
studi
human
birth
cohort
unit
state
ecuador
identifi
fungal
dysbiosi
key
featur
infant
gut
microbiota
signatur
associ
develop
highrisk
asthma
phenotyp
childhood
fujimura
et
al
arrieta
et
al
specif
signatur
fungal
dysbiosi
associ
asthma
relat
phenotyp
differ
studi
notabl
fungal
dysbiosi
much
strike
bacteri
dysbiosi
studi
result
suggest
fungal
dysbiosi
may
readili
detect
biomark
asthma
risk
moreov
studi
found
fungal
dysbiosi
coassoci
bacteri
dysbiosi
fujimura
et
al
arrieta
et
al
call
followup
studi
investig
microbi
immun
mechan
underli
associ
microb
within
gut
influenc
host
immun
respons
microb
interact
physic
metabol
one
anoth
compet
space
nutrient
earli
studi
anim
model
aim
establish
causal
link
fungal
dysbiosi
asthma
sever
demonstr
mice
pretreat
antibiot
suscept
fungal
overgrowth
follow
oral
gavag
common
human
gut
commens
candida
albican
c
albican
noverr
et
al
mice
demonstr
exacerb
cellmedi
airway
inflamm
follow
airway
challeng
noverr
et
al
effect
postul
mediat
least
part
product
immunomodulatori
prostaglandin
c
albican
noverr
et
al
erbdownward
noverr
congruent
overgrowth
anoth
candida
speci
c
parapsilosi
murin
gut
follow
antibiot
treatment
recent
link
prostaglandin
pge
mediat
polar
lung
macrophag
phenotyp
exacerb
allerg
inflamm
follow
antigen
sensit
challeng
model
fungal
overgrowth
correl
inflammatori
immun
cell
infiltr
lung
also
requir
specif
antibioticinduc
chang
bacteri
microbiota
antibiot
caus
reduct
rel
abund
bacteria
genu
among
other
lactobacillu
associ
fungal
overgrowth
exacerb
airway
inflamm
follow
antigen
challeng
kim
et
al
notabl
lactobacillu
lactic
acidproduc
bacteria
interest
use
probiot
protect
asthma
allergi
forsyth
et
al
known
antifung
effect
savag
evid
histor
current
microbi
context
within
fungal
dysbiosi
occur
influenc
associ
immunolog
consequ
asthma
emerg
recent
mice
preexist
mycobiota
demonstr
mix
cell
lung
infiltr
follow
inocul
dysbiot
fugal
commun
wherea
treatment
convent
mice
preexist
mycobiom
result
increas
cell
inflamm
asthma
similarli
fungina
mice
newli
colon
c
albican
demonstr
exacerb
aad
associ
system
expans
fungusspecif
cell
neutrophil
shao
et
al
togeth
studi
highlight
complex
dynam
natur
gut
microbiota
import
crosskingdom
microbi
interact
determin
asthma
outcom
addit
antibiot
treatment
antifung
treatment
induc
chang
bacteri
fungal
commun
gut
specif
pathogenfre
spf
mice
shown
exacerb
type
allerg
airway
inflamm
eosinophilia
hdm
model
aad
wheeler
et
al
li
et
al
continu
supplement
three
fungal
speci
identifi
model
overrepres
gut
follow
antifung
treatment
aspergillu
amstelodami
wallemia
mellicola
sebi
epicoccum
nigrum
wheeler
et
al
li
et
al
wallemia
mellicola
alon
follow
antibiot
treatment
skalski
et
al
similarli
increas
asthma
sever
figur
wheeler
et
al
skalski
et
al
antifung
treatment
introduct
dysbiot
fungal
commun
spf
mice
studi
result
chang
gut
bacteri
commun
includ
deplet
bacteria
lactobacillacea
famili
skalski
et
al
howev
aadexacerb
effect
supplement
dysbiot
fungal
commun
recapitul
alter
schaedler
flora
mice
without
pretreat
antibiot
absenc
substanti
chang
bacteri
microbiota
skalski
et
al
furthermor
li
et
al
recent
demonstr
direct
sens
antifungalinduc
fungal
dysbiosi
gutresid
mononuclear
phagocyt
increas
number
cell
lamina
propria
respons
fungal
dysbiosisassoci
increas
airway
inflamm
hdm
model
aad
independ
antifungalassoci
chang
bacteri
commun
thu
addit
potenti
indirect
effect
airway
inflamm
via
restructur
immunomodulatori
gut
bacteri
popul
product
system
metabolit
asthmaassoci
fungal
dysbiosi
gut
direct
effect
host
innat
adapt
immun
cell
popul
local
fungal
dysbiosi
lung
also
link
asthma
sever
studi
human
shown
small
sampl
subject
children
without
sever
asthma
exhibit
differ
rel
abund
specif
fungi
overal
fungal
divers
bal
sampl
differ
includ
increas
rel
abund
pneumocysti
lung
patient
sever
asthma
goldman
et
al
microb
whose
presenc
within
lung
link
induct
host
type
immun
respons
human
anim
model
edden
et
al
subclin
colon
lung
pneumocysti
month
age
suggest
one
common
infect
infanc
varga
et
al
varga
et
al
associ
increas
mucin
gene
express
rez
et
al
varga
et
al
varga
et
al
varga
et
al
roja
et
al
earli
lung
colon
pneumocysti
may
therefor
repres
risk
factor
induct
cellskew
immun
respons
lung
predispos
infant
asthma
roja
et
al
pyrosequenc
studi
adult
patient
similarli
found
compar
nonatop
control
patient
asthma
demonstr
differ
rel
abund
specif
fungi
pool
sputum
van
woerden
et
al
adult
asthma
demonstr
increas
rel
abund
speci
malassezia
previous
link
allerg
condit
atop
dermat
van
woerden
et
al
overal
pictur
emerg
wherein
patient
asthma
exhibit
increas
rel
abund
specif
fungi
associ
induct
type
inflammatori
immun
pathway
either
absent
present
low
abund
healthi
lung
find
alter
fungal
popul
lung
asthmat
patient
surpris
fungal
compon
mannan
proteas
porter
et
al
chitin
bglucan
van
dyken
et
al
often
found
common
human
allergen
hous
dust
underli
mechan
sensit
remain
unclear
mani
patient
sever
uncontrol
asthma
sensit
fungi
den
et
al
stern
et
al
fraczek
et
al
andor
may
show
improv
asthma
symptom
follow
antifung
therapi
chishimba
et
al
den
et
al
lung
fungi
commonli
associ
sensit
asthma
includ
genera
aspergillu
alternaria
cladosporium
figur
den
et
al
fraczek
et
al
interestingli
evid
anim
model
suggest
sensit
occur
secondari
natur
cell
eosinophil
immun
respons
requir
effect
clearanc
infectioncaus
fungi
porter
et
al
addit
increas
fungal
load
bal
sampl
associ
corticosteroid
therapi
patient
sever
asthma
without
fungal
sensit
fraczek
et
al
thu
futur
work
need
determin
whether
patholog
fungal
colon
mycolog
dysbiosi
lung
caus
onset
sever
asthma
occur
subsequ
sever
asthmaassoci
corticosteroid
treatment
andor
respons
asthmaassoci
chang
lung
microenviron
recent
studi
begun
precis
character
airway
mycobiota
associ
certain
asthma
endotyp
clinic
featur
studi
examin
microbiota
endotrach
brush
bal
fluid
fusarium
cladosporium
alternaria
figur
speci
among
fungal
organ
identifi
enrich
bal
patient
asthma
type
high
asthma
rel
healthi
control
patient
type
low
asthma
respect
sharma
et
al
indic
potenti
use
biomark
diseas
rel
abund
alternaria
cladosporium
bal
fluid
also
neg
associ
forc
expiratori
volum
clinic
measur
lung
function
sharma
et
al
past
coupl
decad
explos
research
composit
immunolog
effect
nonbacteri
member
gut
microbiota
includ
fungi
host
although
much
remain
elucid
robust
bodi
evid
support
substanti
role
fungi
dysbiosisasthma
paradigm
fungalbacteri
fungalhost
interact
play
import
role
determin
effect
fungal
dysbiosi
host
health
much
work
done
pediatr
birth
cohort
mous
model
call
studi
relev
gut
mycobiota
asthma
human
adult
furthermor
earlylif
fungal
dysbiosi
influenc
onset
andor
sever
asthma
later
life
dysbiosi
may
longer
present
remain
mechanist
test
virion
readili
colon
lung
although
viral
infect
known
primari
caus
asthmat
exacerb
relationship
virus
asthma
complet
understood
partli
continu
evolv
knowledg
healthi
virom
respiratori
tract
observ
composit
abund
urt
lrt
virom
differ
among
healthi
subject
asymptomat
symptomat
patient
chronic
respiratori
diseas
detail
longitudin
studi
need
better
comprehens
causal
relationship
sundel
et
al
freer
et
al
complex
interact
virus
addit
environment
intrins
factor
probabl
respons
longer
transient
presenc
virus
respiratori
tract
asthmat
patient
develop
fulli
blown
infect
lead
sever
exacerb
vandini
et
al
sarna
et
al
first
year
human
life
almost
wheez
episod
correl
viral
infect
mikhail
grayson
common
virus
known
induc
wheez
exacerb
asthma
rv
rsv
bocaviru
influenza
viru
cytomegaloviru
cmv
figur
also
implic
meissner
mikhail
grayson
report
earlylif
rvinduc
wheez
addit
effect
asthma
risk
later
life
abund
cell
type
airway
infant
rv
bronchiol
neutrophil
although
infiltr
eosinophil
also
play
import
role
heinonen
et
al
moreov
recent
demonstr
concentr
mast
cell
tnfa
ifna
significantli
higher
stimul
rv
liu
et
al
cell
particip
control
rv
infect
recognit
viral
antigen
subsequ
initi
tc
antibodymedi
immun
respons
heinonen
et
al
particular
interest
recent
studi
show
vitro
rv
enter
form
viral
replic
center
b
lymphocyt
induc
prolifer
b
cell
anoth
viru
link
increas
risk
asthma
rsv
bachari
et
al
howev
associ
diseas
less
clear
kast
et
al
studi
suggest
connect
rsvinduc
bronchiol
asthma
bachari
et
al
other
identifi
correl
rsv
infect
infant
develop
asthma
school
age
wu
et
al
longterm
influenc
rsv
infect
asthma
connect
fact
viru
typic
affect
neonat
lung
develop
jartti
gern
neonat
regulatori
b
cell
highli
permiss
rsv
infect
frequenc
cell
popul
predict
sever
acut
bronchiol
zhivaki
et
al
moreov
rsv
rapidli
adher
human
eosinophil
might
inactiv
cell
capac
eosinophil
captur
viru
reduc
increas
sever
asthma
sabog
ero
et
al
influenza
virus
anoth
viral
infect
connect
asthma
exacerb
coverston
et
al
asthma
set
influenza
infect
associ
wors
sever
higher
risk
hospit
need
intens
care
mortal
ritchi
et
al
hypothes
necessari
drive
influenza
virusinduc
asthma
exacerb
mous
model
asthma
enhanc
airway
hyperrespons
airway
inflamm
suppress
innat
adapt
antivir
respons
ravanetti
et
al
anoth
studi
shown
influenza
infect
induc
airway
hyperreact
pathway
requir
axi
chang
et
al
besid
wellstudi
virus
link
asthma
describ
also
less
commonli
encount
virus
influenc
airway
inflamm
involv
asthma
human
bocaviru
hbov
cmv
also
connect
wheez
episod
children
studi
publish
del
rosal
et
al
report
small
sampl
children
hbov
age
year
previous
hospit
due
acut
bronchiol
develop
recurr
wheez
half
asthma
age
year
also
demonstr
subcutan
inject
protein
ovasensit
mice
result
elev
airway
inflamm
chiang
et
al
final
cmv
dna
detect
patient
recurr
wheez
preval
among
age
month
posit
modifi
asthma
predict
index
mapi
age
group
neg
mapi
connect
respiratori
viral
infect
asthma
develop
recent
investig
use
mechanist
approach
makri
johnston
toussaint
et
al
howev
precis
mechan
respons
correl
still
unclear
need
detail
investig
anim
model
well
human
studi
use
multiom
approach
analys
consid
global
virom
patient
also
consid
futur
final
scientist
also
ask
question
possibl
gut
virus
influenc
lung
inflamm
although
understudi
archaea
consist
identifi
human
microbiota
studi
commun
composit
differ
accord
bodi
site
koskinen
et
al
methonoarchaea
includ
methanobrevibact
smithii
methanosphaera
stadtmana
stadtmana
propos
keyston
member
microbi
commun
possess
immunogen
properti
blai
lecour
et
al
bang
et
al
role
intestin
archaea
dysbiosisasthma
paradigm
recent
suggest
studi
subset
children
koala
birth
cohort
netherland
barnett
et
al
presenc
stadtmana
stool
sampl
children
associ
dosedepend
manner
reduc
risk
diagnos
asthma
barnett
et
al
effect
independ
parent
asthma
statu
barnett
et
al
sampl
test
studi
posit
stadtmana
howev
certain
archaeal
protein
actual
propos
proinflammatori
blai
lecour
et
al
allergen
properti
bragin
et
al
thu
cohort
studi
mechanist
studi
immunomodulatori
effect
gut
archaea
context
asthma
need
case
microbi
commun
discuss
review
microbi
immun
context
within
disrupt
archaeal
commun
occur
like
determin
ultim
immunolog
consequ
host
furthermor
human
lung
microbiota
childhood
adult
continu
character
role
lung
archaea
dysbiosisasthma
paradigm
need
determin
support
rich
bodi
literatur
human
microbiota
influenc
matur
function
host
immun
system
lung
gut
microbiota
impact
asthma
develop
phenotyp
sever
detail
cellular
molecular
mechan
correl
yet
fulli
character
one
import
tool
help
understand
mechan
underli
connect
human
microbiota
immun
system
human
microbiota
mous
model
allerg
airway
inflamm
special
attent
also
given
improv
vivo
anim
model
establish
studi
mimic
human
clinic
condit
close
possibl
current
two
common
mous
model
allerg
airway
inflamm
ova
hdminduc
acut
model
reflect
mainli
type
asthma
model
util
high
allergen
dose
lp
chlamydia
muridarum
haemophilu
influenza
paramyxoviru
usual
addit
allergen
partial
reflect
nontyp
inflamm
use
complement
ova
hdm
model
kim
et
al
thank
advanc
dna
rna
sequenc
technolog
possibl
character
mani
uncultur
microbi
strain
known
associ
asthma
condit
year
ago
recent
analys
use
current
avail
sequenc
method
allow
us
determin
microbi
dysbiosi
gut
lung
airway
inflamm
character
taxaspecif
shift
abund
famili
genu
speci
even
strain
level
data
clearli
show
futur
studi
concentr
specif
chang
microbiota
taxonomi
includ
strain
differ
rather
overal
chang
hand
global
view
microbiota
correl
host
phenotyp
taken
consider
studi
isol
bacteri
strain
context
airway
inflamm
might
differ
outcom
strain
investig
within
bacteri
commun
moreov
emphasi
given
detail
studi
differ
part
human
microbiota
includ
virus
archaea
fungi
bacteriophag
well
parasit
possibl
global
shift
chang
interkingdom
intersit
microbi
interact
within
microbiota
context
asthma
moreov
well
establish
distribut
microbiota
differ
accord
physicochemci
nich
gut
studi
gut
microbi
composit
mice
correl
airway
inflamm
therefor
take
consider
gut
biogeographi
common
approach
analyz
gut
microbiota
analysi
fecal
microbiota
ignor
microb
remain
along
gastrointestin
tract
approach
may
lack
import
inform
potenti
misinterpret
connect
gut
microbiota
host
limit
current
studi
asthma
complex
diseas
character
mani
differ
phenotyp
endotyp
human
cohort
studi
therefor
includ
clearli
defin
clinic
outcom
collect
longitudin
data
detail
specifi
question
symptom
treatment
clinic
inform
complet
inform
regard
patient
diet
lifestyl
also
care
prepar
ensur
best
overview
patient
condit
potenti
influenc
microbiota
futur
studi
extend
includ
sever
time
point
patient
life
determin
whether
chang
earlierlif
microbiota
connect
asthma
develop
prevent
increas
improv
airway
inflamm
importantli
longitudin
prospect
analys
larger
cohort
patient
need
understand
relationship
cours
diseas
phenotyp
endotyp
suscept
diseas
progress
respons
treatment
final
consider
attent
continu
paid
earlylif
chang
gut
lung
microbiota
influenc
allergi
symptom
later
life
indisput
earli
life
import
period
microbiom
dysbiosi
may
lead
develop
immunemedi
diseas
also
abl
answer
question
still
possibl
chang
modul
microbiota
allerg
diseas
condit
later
life
even
earlylif
period
neglect
summar
clear
futur
diagnosi
treatment
patient
asthma
assist
analysi
composit
metabol
activ
individu
microbiom
clinic
studi
new
therapeut
consid
includ
microbiom
metabolit
analys
determin
whether
microbiom
featur
correl
respons
treatment
mechanist
epidemiolog
studi
need
uncov
function
multidirect
associ
specif
microbiota
strain
host
immun
system
allergen
